Cite
P890: THE OUTCOME OF SECOND PRIMARY MALIGNANCIES DEVELOPING IN MM PATIENTS
MLA
I. Avivi, et al. “P890: The Outcome of Second Primary Malignancies Developing in Mm Patients.” HemaSphere, vol. 6, June 2022, pp. 782–83. EBSCOhost, https://doi.org/10.1097/01.HS9.0000846436.07526.da.
APA
I. Avivi, D. H vesole, J. Dávila Valls, L. Usnarska-Zubkiewicz, V. Milunovic, B. B. Bogumiła Osękowska, A. Kopińska, M. Gentile, B. P. Martínez, P. Robak, E. crusoe, R. Luis Gerardo, M. Gajewska, V. Gergely, M. Delforge, Y. Cohen, G. Alessandro, C. peña, C. Shustik, … A. Jurczyszyn. (2022). P890: The Outcome of Second Primary Malignancies Developing in Mm Patients. HemaSphere, 6, 782–783. https://doi.org/10.1097/01.HS9.0000846436.07526.da
Chicago
I. Avivi, D. H vesole, J. Dávila Valls, L. Usnarska-Zubkiewicz, V. Milunovic, B. B. Bogumiła Osękowska, A. Kopińska, et al. 2022. “P890: The Outcome of Second Primary Malignancies Developing in Mm Patients.” HemaSphere 6 (June): 782–83. doi:10.1097/01.HS9.0000846436.07526.da.